Select a community
All Communities
Home > Community Treatment Reports > Irbesartan Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Irbesartan Treatment Report

Brand Names: Avapro
Generic Name: Irbesartan

What is Irbesartan? Irbesartan is a antihypertensive agent sold under the brand name Avapro®. It is used in the treatment of hypertension alone or in combination with other antihypertensives. Also used in the treatment of diabetic nephropathy in patients with noninsulin dependent diabetes and hypertension.

See more information, including instructions, precautions, side effects, and interactions.


Reasons taken

24 patients in the community are taking or have taken Irbesartan.

Reason # Patients Percentage of patients
High blood pressure (Hypertension) 8 33%
General health 6 25%
Other 5 20%
blood pressure high 3 12%

Dosages

Based on the patients currently taking Irbesartan.

  75 mg daily 150 mg daily 200 mg daily 300 mg daily
  2 Number of Patients: 2 9 Number of Patients: 9 1 Number of Patients: 1 8 Number of Patients: 8  

Duration

How long current patients have been taking Irbesartan or how long patients were taking Irbesartan before stopping.

Currently Taking Irbesartan

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
2
3
6

Stopped Taking Irbesartan

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
0
2
1
Why Patients Stopped Taking Irbesartan (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 2 50% Other: 50%
Did not seem to work 1 25% Did not seem to work: 25%
Doctor's advice 1 25% Doctor's advice: 25%
Side effects too severe 1 25% Side effects too severe: 25%
Course of treatment ended 1 25% Course of treatment ended: 25%

Patient Reported Evaluations

Results from 4 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 33% 1
Moderate 67% 2

Other

Side-effects (as an overall problem)

Severe 0% 0
Moderate 25% 1
Mild 25% 1
None 50% 2

Top reported side-effects include: Low blood pressure (hypotension), less energy

Summary results are based on 4 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 4)

  • thjuland
    Sex: M
    Sensation: Mild
    Overall: Mild
    Cognition: moderate
    Vision: moderate
    Speech: mild
    Swallowing: none
    Upper limb: moderate
    Walking: moderate
  • thjuland
  • by thjuland
    Nov 07, 2008
  • EfficacyModerate
  • Side-effectsMild
  • Other

See all evaluation results for Irbesartan

Report created on November 07, 2009.